nodes	percent_of_prediction	percent_of_DWPC	metapath
Morphine—UGT1A1—Abacavir—acquired immunodeficiency syndrome	0.136	0.202	CbGbCtD
Morphine—UGT2B7—Zidovudine—acquired immunodeficiency syndrome	0.0736	0.11	CbGbCtD
Morphine—CYP2C8—Delavirdine—acquired immunodeficiency syndrome	0.0257	0.0382	CbGbCtD
Morphine—CYP2C8—Amprenavir—acquired immunodeficiency syndrome	0.0257	0.0382	CbGbCtD
Morphine—CYP2C8—Ritonavir—acquired immunodeficiency syndrome	0.0194	0.029	CbGbCtD
Morphine—CYP2C8—Saquinavir—acquired immunodeficiency syndrome	0.0194	0.029	CbGbCtD
Morphine—CYP2D6—Efavirenz—acquired immunodeficiency syndrome	0.0193	0.0287	CbGbCtD
Morphine—ABCB1—Lopinavir—acquired immunodeficiency syndrome	0.0192	0.0286	CbGbCtD
Morphine—CYP2C8—Zidovudine—acquired immunodeficiency syndrome	0.0186	0.0278	CbGbCtD
Morphine—CYP2D6—Nevirapine—acquired immunodeficiency syndrome	0.0181	0.027	CbGbCtD
Morphine—CYP2D6—Lopinavir—acquired immunodeficiency syndrome	0.0181	0.027	CbGbCtD
Morphine—ABCB1—Amprenavir—acquired immunodeficiency syndrome	0.0174	0.0259	CbGbCtD
Morphine—CYP2D6—Delavirdine—acquired immunodeficiency syndrome	0.0164	0.0244	CbGbCtD
Morphine—CYP2D6—Amprenavir—acquired immunodeficiency syndrome	0.0164	0.0244	CbGbCtD
Morphine—ABCB1—Indinavir—acquired immunodeficiency syndrome	0.015	0.0223	CbGbCtD
Morphine—ABCB1—Nelfinavir—acquired immunodeficiency syndrome	0.0146	0.0217	CbGbCtD
Morphine—CYP2D6—Indinavir—acquired immunodeficiency syndrome	0.0141	0.021	CbGbCtD
Morphine—CYP2D6—Nelfinavir—acquired immunodeficiency syndrome	0.0137	0.0204	CbGbCtD
Morphine—ABCB1—Ritonavir—acquired immunodeficiency syndrome	0.0132	0.0196	CbGbCtD
Morphine—ABCB1—Saquinavir—acquired immunodeficiency syndrome	0.0132	0.0196	CbGbCtD
Morphine—ABCB1—Zidovudine—acquired immunodeficiency syndrome	0.0126	0.0188	CbGbCtD
Morphine—CYP2D6—Ritonavir—acquired immunodeficiency syndrome	0.0124	0.0185	CbGbCtD
Morphine—CYP2D6—Saquinavir—acquired immunodeficiency syndrome	0.0124	0.0185	CbGbCtD
Morphine—CYP3A4—Efavirenz—acquired immunodeficiency syndrome	0.0122	0.0182	CbGbCtD
Morphine—CYP3A4—Lopinavir—acquired immunodeficiency syndrome	0.0115	0.0171	CbGbCtD
Morphine—CYP3A4—Nevirapine—acquired immunodeficiency syndrome	0.0115	0.0171	CbGbCtD
Morphine—CYP3A4—Amprenavir—acquired immunodeficiency syndrome	0.0104	0.0155	CbGbCtD
Morphine—CYP3A4—Delavirdine—acquired immunodeficiency syndrome	0.0104	0.0155	CbGbCtD
Morphine—ABCB1—Lamivudine—acquired immunodeficiency syndrome	0.00976	0.0145	CbGbCtD
Morphine—CYP3A4—Indinavir—acquired immunodeficiency syndrome	0.00898	0.0134	CbGbCtD
Morphine—CYP3A4—Nelfinavir—acquired immunodeficiency syndrome	0.00872	0.013	CbGbCtD
Morphine—CYP3A4—Saquinavir—acquired immunodeficiency syndrome	0.00789	0.0117	CbGbCtD
Morphine—CYP3A4—Ritonavir—acquired immunodeficiency syndrome	0.00789	0.0117	CbGbCtD
Morphine—CYP3A4—Zidovudine—acquired immunodeficiency syndrome	0.00756	0.0113	CbGbCtD
Morphine—OPRM1—nerve—acquired immunodeficiency syndrome	0.00252	0.0585	CbGeAlD
Morphine—UGT1A1—blood plasma—acquired immunodeficiency syndrome	0.00242	0.0562	CbGeAlD
Morphine—UGT1A8—digestive system—acquired immunodeficiency syndrome	0.00214	0.0497	CbGeAlD
Morphine—OPRL1—lymphoid tissue—acquired immunodeficiency syndrome	0.00211	0.049	CbGeAlD
Morphine—OPRL1—blood—acquired immunodeficiency syndrome	0.00199	0.0461	CbGeAlD
Morphine—OPRL1—spinal cord—acquired immunodeficiency syndrome	0.00192	0.0444	CbGeAlD
Morphine—UGT1A3—digestive system—acquired immunodeficiency syndrome	0.00191	0.0443	CbGeAlD
Morphine—UGT2B15—digestive system—acquired immunodeficiency syndrome	0.00179	0.0416	CbGeAlD
Morphine—UGT2B4—lung—acquired immunodeficiency syndrome	0.00166	0.0386	CbGeAlD
Morphine—OPRL1—nervous system—acquired immunodeficiency syndrome	0.00161	0.0374	CbGeAlD
Morphine—OPRL1—central nervous system—acquired immunodeficiency syndrome	0.00155	0.036	CbGeAlD
Morphine—OPRL1—brain—acquired immunodeficiency syndrome	0.00123	0.0286	CbGeAlD
Morphine—OPRL1—lymph node—acquired immunodeficiency syndrome	0.00119	0.0276	CbGeAlD
Morphine—CYP2C8—blood plasma—acquired immunodeficiency syndrome	0.00115	0.0266	CbGeAlD
Morphine—UGT2B7—digestive system—acquired immunodeficiency syndrome	0.0011	0.0254	CbGeAlD
Morphine—UGT1A1—digestive system—acquired immunodeficiency syndrome	0.000932	0.0216	CbGeAlD
Morphine—UGT1A1—blood—acquired immunodeficiency syndrome	0.000888	0.0206	CbGeAlD
Morphine—OPRD1—nervous system—acquired immunodeficiency syndrome	0.000831	0.0193	CbGeAlD
Morphine—OPRD1—central nervous system—acquired immunodeficiency syndrome	0.0008	0.0186	CbGeAlD
Morphine—OPRK1—nervous system—acquired immunodeficiency syndrome	0.000797	0.0185	CbGeAlD
Morphine—CYP3A4—blood plasma—acquired immunodeficiency syndrome	0.000777	0.018	CbGeAlD
Morphine—OPRK1—central nervous system—acquired immunodeficiency syndrome	0.000767	0.0178	CbGeAlD
Morphine—CYP2D6—blood plasma—acquired immunodeficiency syndrome	0.000764	0.0177	CbGeAlD
Morphine—OPRM1—blood—acquired immunodeficiency syndrome	0.000699	0.0162	CbGeAlD
Morphine—OPRM1—spinal cord—acquired immunodeficiency syndrome	0.000673	0.0156	CbGeAlD
Morphine—OPRD1—brain—acquired immunodeficiency syndrome	0.000636	0.0147	CbGeAlD
Morphine—OPRK1—brain—acquired immunodeficiency syndrome	0.000609	0.0141	CbGeAlD
Morphine—OPRM1—nervous system—acquired immunodeficiency syndrome	0.000567	0.0131	CbGeAlD
Morphine—ABCB1—blood plasma—acquired immunodeficiency syndrome	0.00055	0.0128	CbGeAlD
Morphine—OPRM1—central nervous system—acquired immunodeficiency syndrome	0.000546	0.0127	CbGeAlD
Morphine—OPRM1—brain—acquired immunodeficiency syndrome	0.000433	0.0101	CbGeAlD
Morphine—CYP2C8—blood—acquired immunodeficiency syndrome	0.00042	0.00974	CbGeAlD
Morphine—CYP2C8—vagina—acquired immunodeficiency syndrome	0.000389	0.00903	CbGeAlD
Morphine—ABCB1—retina—acquired immunodeficiency syndrome	0.000301	0.00698	CbGeAlD
Morphine—CYP3A4—digestive system—acquired immunodeficiency syndrome	0.000299	0.00693	CbGeAlD
Morphine—CYP2D6—digestive system—acquired immunodeficiency syndrome	0.000294	0.00682	CbGeAlD
Morphine—CYP3A4—blood—acquired immunodeficiency syndrome	0.000285	0.0066	CbGeAlD
Morphine—CYP2D6—blood—acquired immunodeficiency syndrome	0.00028	0.00649	CbGeAlD
Morphine—CYP2C8—brain—acquired immunodeficiency syndrome	0.000261	0.00605	CbGeAlD
Morphine—CYP3A4—nervous system—acquired immunodeficiency syndrome	0.000231	0.00536	CbGeAlD
Morphine—CYP2D6—nervous system—acquired immunodeficiency syndrome	0.000227	0.00527	CbGeAlD
Morphine—CYP3A4—central nervous system—acquired immunodeficiency syndrome	0.000222	0.00516	CbGeAlD
Morphine—CYP2D6—central nervous system—acquired immunodeficiency syndrome	0.000219	0.00508	CbGeAlD
Morphine—ABCB1—lymphoid tissue—acquired immunodeficiency syndrome	0.000214	0.00496	CbGeAlD
Morphine—ABCB1—digestive system—acquired immunodeficiency syndrome	0.000211	0.0049	CbGeAlD
Morphine—ABCB1—blood—acquired immunodeficiency syndrome	0.000201	0.00467	CbGeAlD
Morphine—ABCB1—bone marrow—acquired immunodeficiency syndrome	0.000195	0.00452	CbGeAlD
Morphine—ABCB1—spinal cord—acquired immunodeficiency syndrome	0.000194	0.0045	CbGeAlD
Morphine—ABCB1—vagina—acquired immunodeficiency syndrome	0.000187	0.00433	CbGeAlD
Morphine—ABCB1—lung—acquired immunodeficiency syndrome	0.000177	0.00409	CbGeAlD
Morphine—CYP2D6—brain—acquired immunodeficiency syndrome	0.000174	0.00403	CbGeAlD
Morphine—OPRK1—Peptide ligand-binding receptors—CCR2—acquired immunodeficiency syndrome	0.000172	0.0032	CbGpPWpGaD
Morphine—OPRM1—TCR Signaling Pathway—CCR5—acquired immunodeficiency syndrome	0.00017	0.00317	CbGpPWpGaD
Morphine—OPRL1—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	0.000168	0.00312	CbGpPWpGaD
Morphine—UGT2B15—Metabolism—AGPS—acquired immunodeficiency syndrome	0.000167	0.0031	CbGpPWpGaD
Morphine—UGT2B4—Metabolism—AGPS—acquired immunodeficiency syndrome	0.000167	0.0031	CbGpPWpGaD
Morphine—OPRD1—G alpha (i) signalling events—CCR2—acquired immunodeficiency syndrome	0.000166	0.00308	CbGpPWpGaD
Morphine—ABCB1—nervous system—acquired immunodeficiency syndrome	0.000164	0.00379	CbGeAlD
Morphine—OPRD1—GPCR ligand binding—CCL4—acquired immunodeficiency syndrome	0.000162	0.00302	CbGpPWpGaD
Morphine—OPRK1—Peptide ligand-binding receptors—CXCL12—acquired immunodeficiency syndrome	0.000162	0.00301	CbGpPWpGaD
Morphine—OPRK1—Peptide ligand-binding receptors—CXCR4—acquired immunodeficiency syndrome	0.000162	0.00301	CbGpPWpGaD
Morphine—OPRM1—Peptide ligand-binding receptors—CCL3—acquired immunodeficiency syndrome	0.000161	0.00299	CbGpPWpGaD
Morphine—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCL4—acquired immunodeficiency syndrome	0.000158	0.00293	CbGpPWpGaD
Morphine—ABCB1—central nervous system—acquired immunodeficiency syndrome	0.000157	0.00365	CbGeAlD
Morphine—OPRK1—GPCR ligand binding—ACKR1—acquired immunodeficiency syndrome	0.000157	0.00292	CbGpPWpGaD
Morphine—OPRD1—G alpha (i) signalling events—CXCL12—acquired immunodeficiency syndrome	0.000156	0.00289	CbGpPWpGaD
Morphine—OPRD1—G alpha (i) signalling events—CXCR4—acquired immunodeficiency syndrome	0.000156	0.00289	CbGpPWpGaD
Morphine—OPRD1—GPCRs, Class A Rhodopsin-like—CCR2—acquired immunodeficiency syndrome	0.000154	0.00285	CbGpPWpGaD
Morphine—OPRD1—Signaling by GPCR—CCL3L1—acquired immunodeficiency syndrome	0.000152	0.00282	CbGpPWpGaD
Morphine—OPRL1—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	0.000151	0.00281	CbGpPWpGaD
Morphine—ABCB1—HIF-1-alpha transcription factor network—CXCR4—acquired immunodeficiency syndrome	0.000149	0.00278	CbGpPWpGaD
Morphine—ABCB1—HIF-1-alpha transcription factor network—CXCL12—acquired immunodeficiency syndrome	0.000149	0.00278	CbGpPWpGaD
Morphine—OPRD1—Class A/1 (Rhodopsin-like receptors)—CCL3—acquired immunodeficiency syndrome	0.000146	0.0027	CbGpPWpGaD
Morphine—OPRM1—Peptide ligand-binding receptors—CCR2—acquired immunodeficiency syndrome	0.000145	0.0027	CbGpPWpGaD
Morphine—OPRK1—G alpha (i) signalling events—CCR2—acquired immunodeficiency syndrome	0.000145	0.0027	CbGpPWpGaD
Morphine—OPRD1—GPCRs, Class A Rhodopsin-like—CXCR4—acquired immunodeficiency syndrome	0.000144	0.00268	CbGpPWpGaD
Morphine—OPRK1—GPCR ligand binding—CCL4—acquired immunodeficiency syndrome	0.000142	0.00264	CbGpPWpGaD
Morphine—OPRD1—Peptide ligand-binding receptors—CCL5—acquired immunodeficiency syndrome	0.00014	0.00261	CbGpPWpGaD
Morphine—OPRM1—Peptide ligand-binding receptors—CXCL12—acquired immunodeficiency syndrome	0.000137	0.00254	CbGpPWpGaD
Morphine—OPRM1—Peptide ligand-binding receptors—CXCR4—acquired immunodeficiency syndrome	0.000137	0.00254	CbGpPWpGaD
Morphine—OPRK1—G alpha (i) signalling events—CXCR4—acquired immunodeficiency syndrome	0.000136	0.00254	CbGpPWpGaD
Morphine—OPRK1—G alpha (i) signalling events—CXCL12—acquired immunodeficiency syndrome	0.000136	0.00254	CbGpPWpGaD
Morphine—OPRK1—GPCRs, Class A Rhodopsin-like—CCR2—acquired immunodeficiency syndrome	0.000135	0.0025	CbGpPWpGaD
Morphine—OPRK1—Signaling by GPCR—CCL3L1—acquired immunodeficiency syndrome	0.000133	0.00248	CbGpPWpGaD
Morphine—OPRL1—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	0.000133	0.00248	CbGpPWpGaD
Morphine—OPRM1—GPCR ligand binding—ACKR1—acquired immunodeficiency syndrome	0.000133	0.00247	CbGpPWpGaD
Morphine—OPRL1—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	0.000133	0.00247	CbGpPWpGaD
Morphine—OPRD1—Class A/1 (Rhodopsin-like receptors)—CCR2—acquired immunodeficiency syndrome	0.000132	0.00245	CbGpPWpGaD
Morphine—ABCB1—Allograft Rejection—CXCL12—acquired immunodeficiency syndrome	0.000129	0.00241	CbGpPWpGaD
Morphine—OPRK1—Class A/1 (Rhodopsin-like receptors)—CCL3—acquired immunodeficiency syndrome	0.000128	0.00237	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.000127	0.00237	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.000127	0.00237	CbGpPWpGaD
Morphine—OPRK1—GPCRs, Class A Rhodopsin-like—CXCR4—acquired immunodeficiency syndrome	0.000127	0.00235	CbGpPWpGaD
Morphine—OPRD1—Peptide ligand-binding receptors—CCR5—acquired immunodeficiency syndrome	0.000126	0.00235	CbGpPWpGaD
Morphine—UGT1A1—Aryl Hydrocarbon Receptor Pathway—TNF—acquired immunodeficiency syndrome	0.000125	0.00233	CbGpPWpGaD
Morphine—ABCB1—brain—acquired immunodeficiency syndrome	0.000125	0.0029	CbGeAlD
Morphine—OPRL1—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	0.000125	0.00232	CbGpPWpGaD
Morphine—OPRL1—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	0.000125	0.00232	CbGpPWpGaD
Morphine—OPRD1—Class A/1 (Rhodopsin-like receptors)—CXCL12—acquired immunodeficiency syndrome	0.000124	0.0023	CbGpPWpGaD
Morphine—OPRD1—Class A/1 (Rhodopsin-like receptors)—CXCR4—acquired immunodeficiency syndrome	0.000124	0.0023	CbGpPWpGaD
Morphine—OPRK1—Peptide ligand-binding receptors—CCL5—acquired immunodeficiency syndrome	0.000123	0.00229	CbGpPWpGaD
Morphine—OPRM1—G alpha (i) signalling events—CCR2—acquired immunodeficiency syndrome	0.000123	0.00228	CbGpPWpGaD
Morphine—ABCB1—lymph node—acquired immunodeficiency syndrome	0.000121	0.0028	CbGeAlD
Morphine—OPRL1—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	0.000121	0.00224	CbGpPWpGaD
Morphine—OPRM1—GPCR ligand binding—CCL4—acquired immunodeficiency syndrome	0.00012	0.00223	CbGpPWpGaD
Morphine—OPRD1—G alpha (i) signalling events—CCL5—acquired immunodeficiency syndrome	0.000118	0.0022	CbGpPWpGaD
Morphine—OPRK1—Class A/1 (Rhodopsin-like receptors)—CCR2—acquired immunodeficiency syndrome	0.000115	0.00214	CbGpPWpGaD
Morphine—OPRM1—G alpha (i) signalling events—CXCR4—acquired immunodeficiency syndrome	0.000115	0.00214	CbGpPWpGaD
Morphine—OPRM1—G alpha (i) signalling events—CXCL12—acquired immunodeficiency syndrome	0.000115	0.00214	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.000115	0.00214	CbGpPWpGaD
Morphine—Anaemia—Lamivudine—acquired immunodeficiency syndrome	0.000115	0.000495	CcSEcCtD
Morphine—Anxiety—Ritonavir—acquired immunodeficiency syndrome	0.000115	0.000494	CcSEcCtD
Morphine—Loss of consciousness—Saquinavir—acquired immunodeficiency syndrome	0.000114	0.000493	CcSEcCtD
Morphine—Unspecified disorder of skin and subcutaneous tissue—Ritonavir—acquired immunodeficiency syndrome	0.000114	0.000493	CcSEcCtD
Morphine—OPRM1—GPCRs, Class A Rhodopsin-like—CCR2—acquired immunodeficiency syndrome	0.000114	0.00212	CbGpPWpGaD
Morphine—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	0.000114	0.000491	CcSEcCtD
Morphine—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.000114	0.000491	CcSEcCtD
Morphine—Fatigue—Indinavir—acquired immunodeficiency syndrome	0.000114	0.00049	CcSEcCtD
Morphine—Anorexia—Delavirdine—acquired immunodeficiency syndrome	0.000114	0.00049	CcSEcCtD
Morphine—Discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000114	0.00049	CcSEcCtD
Morphine—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	0.000113	0.00049	CcSEcCtD
Morphine—Cough—Saquinavir—acquired immunodeficiency syndrome	0.000113	0.000489	CcSEcCtD
Morphine—OPRL1—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.000113	0.00211	CbGpPWpGaD
Morphine—OPRL1—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.000113	0.00211	CbGpPWpGaD
Morphine—Constipation—Indinavir—acquired immunodeficiency syndrome	0.000113	0.000486	CcSEcCtD
Morphine—Pain—Indinavir—acquired immunodeficiency syndrome	0.000113	0.000486	CcSEcCtD
Morphine—Insomnia—Efavirenz—acquired immunodeficiency syndrome	0.000113	0.000486	CcSEcCtD
Morphine—OPRM1—Signaling by GPCR—CCL3L1—acquired immunodeficiency syndrome	0.000113	0.00209	CbGpPWpGaD
Morphine—Urticaria—Zidovudine—acquired immunodeficiency syndrome	0.000113	0.000486	CcSEcCtD
Morphine—Convulsion—Saquinavir—acquired immunodeficiency syndrome	0.000113	0.000486	CcSEcCtD
Morphine—Dry mouth—Ritonavir—acquired immunodeficiency syndrome	0.000112	0.000485	CcSEcCtD
Morphine—Hypertension—Saquinavir—acquired immunodeficiency syndrome	0.000112	0.000484	CcSEcCtD
Morphine—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	0.000112	0.000484	CcSEcCtD
Morphine—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	0.000112	0.000484	CcSEcCtD
Morphine—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.000112	0.000483	CcSEcCtD
Morphine—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	0.000112	0.000483	CcSEcCtD
Morphine—Malaise—Lamivudine—acquired immunodeficiency syndrome	0.000112	0.000483	CcSEcCtD
Morphine—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.000112	0.000482	CcSEcCtD
Morphine—Nausea—Didanosine—acquired immunodeficiency syndrome	0.000112	0.000482	CcSEcCtD
Morphine—Vertigo—Lamivudine—acquired immunodeficiency syndrome	0.000111	0.000481	CcSEcCtD
Morphine—Hypotension—Delavirdine—acquired immunodeficiency syndrome	0.000111	0.000481	CcSEcCtD
Morphine—Syncope—Lamivudine—acquired immunodeficiency syndrome	0.000111	0.00048	CcSEcCtD
Morphine—Confusional state—Ritonavir—acquired immunodeficiency syndrome	0.000111	0.00048	CcSEcCtD
Morphine—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	0.000111	0.000479	CcSEcCtD
Morphine—Leukopenia—Lamivudine—acquired immunodeficiency syndrome	0.000111	0.000479	CcSEcCtD
Morphine—OPRK1—Peptide ligand-binding receptors—CCR5—acquired immunodeficiency syndrome	0.000111	0.00206	CbGpPWpGaD
Morphine—OPRD1—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	0.000111	0.00206	CbGpPWpGaD
Morphine—Somnolence—Efavirenz—acquired immunodeficiency syndrome	0.000111	0.000478	CcSEcCtD
Morphine—Arthralgia—Saquinavir—acquired immunodeficiency syndrome	0.000111	0.000478	CcSEcCtD
Morphine—Chest pain—Saquinavir—acquired immunodeficiency syndrome	0.000111	0.000478	CcSEcCtD
Morphine—Anxiety—Saquinavir—acquired immunodeficiency syndrome	0.00011	0.000476	CcSEcCtD
Morphine—Oedema—Ritonavir—acquired immunodeficiency syndrome	0.00011	0.000476	CcSEcCtD
Morphine—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.00011	0.000474	CcSEcCtD
Morphine—Unspecified disorder of skin and subcutaneous tissue—Saquinavir—acquired immunodeficiency syndrome	0.00011	0.000474	CcSEcCtD
Morphine—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	0.00011	0.000473	CcSEcCtD
Morphine—Discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000109	0.000472	CcSEcCtD
Morphine—Loss of consciousness—Lamivudine—acquired immunodeficiency syndrome	0.000109	0.00047	CcSEcCtD
Morphine—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	0.000109	0.000469	CcSEcCtD
Morphine—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	0.000109	0.000469	CcSEcCtD
Morphine—OPRK1—Class A/1 (Rhodopsin-like receptors)—CXCL12—acquired immunodeficiency syndrome	0.000109	0.00202	CbGpPWpGaD
Morphine—OPRK1—Class A/1 (Rhodopsin-like receptors)—CXCR4—acquired immunodeficiency syndrome	0.000109	0.00202	CbGpPWpGaD
Morphine—Shock—Ritonavir—acquired immunodeficiency syndrome	0.000108	0.000468	CcSEcCtD
Morphine—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	0.000108	0.000467	CcSEcCtD
Morphine—Dry mouth—Saquinavir—acquired immunodeficiency syndrome	0.000108	0.000467	CcSEcCtD
Morphine—Cough—Lamivudine—acquired immunodeficiency syndrome	0.000108	0.000467	CcSEcCtD
Morphine—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.000108	0.000467	CcSEcCtD
Morphine—Nervous system disorder—Ritonavir—acquired immunodeficiency syndrome	0.000108	0.000466	CcSEcCtD
Morphine—Thrombocytopenia—Ritonavir—acquired immunodeficiency syndrome	0.000108	0.000466	CcSEcCtD
Morphine—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCL3—acquired immunodeficiency syndrome	0.000108	0.002	CbGpPWpGaD
Morphine—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.000108	0.000465	CcSEcCtD
Morphine—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	0.000108	0.000465	CcSEcCtD
Morphine—Insomnia—Delavirdine—acquired immunodeficiency syndrome	0.000108	0.000465	CcSEcCtD
Morphine—Tachycardia—Ritonavir—acquired immunodeficiency syndrome	0.000108	0.000464	CcSEcCtD
Morphine—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	0.000108	0.000464	CcSEcCtD
Morphine—Convulsion—Lamivudine—acquired immunodeficiency syndrome	0.000107	0.000464	CcSEcCtD
Morphine—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.000107	0.000463	CcSEcCtD
Morphine—Fatigue—Efavirenz—acquired immunodeficiency syndrome	0.000107	0.000463	CcSEcCtD
Morphine—OPRM1—GPCRs, Class A Rhodopsin-like—CXCR4—acquired immunodeficiency syndrome	0.000107	0.00199	CbGpPWpGaD
Morphine—Skin disorder—Ritonavir—acquired immunodeficiency syndrome	0.000107	0.000462	CcSEcCtD
Morphine—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	0.000107	0.000462	CcSEcCtD
Morphine—OPRM1—TCR Signaling Pathway—CD4—acquired immunodeficiency syndrome	0.000107	0.00199	CbGpPWpGaD
Morphine—Confusional state—Saquinavir—acquired immunodeficiency syndrome	0.000107	0.000462	CcSEcCtD
Morphine—OPRD1—G alpha (i) signalling events—CCR5—acquired immunodeficiency syndrome	0.000107	0.00198	CbGpPWpGaD
Morphine—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	0.000107	0.00046	CcSEcCtD
Morphine—Constipation—Efavirenz—acquired immunodeficiency syndrome	0.000107	0.00046	CcSEcCtD
Morphine—Pain—Efavirenz—acquired immunodeficiency syndrome	0.000107	0.00046	CcSEcCtD
Morphine—Rash—Nevirapine—acquired immunodeficiency syndrome	0.000107	0.00046	CcSEcCtD
Morphine—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.000106	0.000459	CcSEcCtD
Morphine—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	0.000106	0.000459	CcSEcCtD
Morphine—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.000106	0.000458	CcSEcCtD
Morphine—Oedema—Saquinavir—acquired immunodeficiency syndrome	0.000106	0.000458	CcSEcCtD
Morphine—Somnolence—Delavirdine—acquired immunodeficiency syndrome	0.000106	0.000457	CcSEcCtD
Morphine—Headache—Nevirapine—acquired immunodeficiency syndrome	0.000106	0.000457	CcSEcCtD
Morphine—Arthralgia—Lamivudine—acquired immunodeficiency syndrome	0.000106	0.000456	CcSEcCtD
Morphine—Chest pain—Lamivudine—acquired immunodeficiency syndrome	0.000106	0.000456	CcSEcCtD
Morphine—Infection—Saquinavir—acquired immunodeficiency syndrome	0.000105	0.000455	CcSEcCtD
Morphine—Anxiety—Lamivudine—acquired immunodeficiency syndrome	0.000105	0.000454	CcSEcCtD
Morphine—Anorexia—Ritonavir—acquired immunodeficiency syndrome	0.000105	0.000453	CcSEcCtD
Morphine—UGT1A3—Metabolism—TAT—acquired immunodeficiency syndrome	0.000105	0.00195	CbGpPWpGaD
Morphine—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	0.000105	0.000453	CcSEcCtD
Morphine—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—acquired immunodeficiency syndrome	0.000105	0.000452	CcSEcCtD
Morphine—Urticaria—Indinavir—acquired immunodeficiency syndrome	0.000105	0.000452	CcSEcCtD
Morphine—Shock—Saquinavir—acquired immunodeficiency syndrome	0.000104	0.00045	CcSEcCtD
Morphine—Discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000104	0.00045	CcSEcCtD
Morphine—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	0.000104	0.00045	CcSEcCtD
Morphine—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	0.000104	0.00045	CcSEcCtD
Morphine—Nervous system disorder—Saquinavir—acquired immunodeficiency syndrome	0.000104	0.000449	CcSEcCtD
Morphine—OPRM1—Peptide ligand-binding receptors—CCL5—acquired immunodeficiency syndrome	0.000104	0.00193	CbGpPWpGaD
Morphine—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.000104	0.000449	CcSEcCtD
Morphine—Thrombocytopenia—Saquinavir—acquired immunodeficiency syndrome	0.000104	0.000448	CcSEcCtD
Morphine—OPRK1—G alpha (i) signalling events—CCL5—acquired immunodeficiency syndrome	0.000104	0.00193	CbGpPWpGaD
Morphine—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.000104	0.000447	CcSEcCtD
Morphine—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	0.000104	0.000447	CcSEcCtD
Morphine—Dry mouth—Lamivudine—acquired immunodeficiency syndrome	0.000103	0.000446	CcSEcCtD
Morphine—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.000103	0.000445	CcSEcCtD
Morphine—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.000103	0.000445	CcSEcCtD
Morphine—Skin disorder—Saquinavir—acquired immunodeficiency syndrome	0.000103	0.000445	CcSEcCtD
Morphine—Hypotension—Ritonavir—acquired immunodeficiency syndrome	0.000103	0.000444	CcSEcCtD
Morphine—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	0.000103	0.000444	CcSEcCtD
Morphine—Rash—Stavudine—acquired immunodeficiency syndrome	0.000103	0.000444	CcSEcCtD
Morphine—Fatigue—Delavirdine—acquired immunodeficiency syndrome	0.000103	0.000443	CcSEcCtD
Morphine—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.000103	0.000443	CcSEcCtD
Morphine—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	0.000103	0.000443	CcSEcCtD
Morphine—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	0.000103	0.000443	CcSEcCtD
Morphine—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.000102	0.000442	CcSEcCtD
Morphine—Headache—Stavudine—acquired immunodeficiency syndrome	0.000102	0.000441	CcSEcCtD
Morphine—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.000102	0.000441	CcSEcCtD
Morphine—Confusional state—Lamivudine—acquired immunodeficiency syndrome	0.000102	0.00044	CcSEcCtD
Morphine—Constipation—Delavirdine—acquired immunodeficiency syndrome	0.000102	0.00044	CcSEcCtD
Morphine—Pain—Delavirdine—acquired immunodeficiency syndrome	0.000102	0.00044	CcSEcCtD
Morphine—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	0.000102	0.00044	CcSEcCtD
Morphine—Asthenia—Zidovudine—acquired immunodeficiency syndrome	0.000102	0.000439	CcSEcCtD
Morphine—Rash—Abacavir—acquired immunodeficiency syndrome	0.000101	0.000437	CcSEcCtD
Morphine—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.000101	0.000437	CcSEcCtD
Morphine—Oedema—Lamivudine—acquired immunodeficiency syndrome	0.000101	0.000437	CcSEcCtD
Morphine—Anaphylactic shock—Lamivudine—acquired immunodeficiency syndrome	0.000101	0.000437	CcSEcCtD
Morphine—Anorexia—Saquinavir—acquired immunodeficiency syndrome	0.000101	0.000436	CcSEcCtD
Morphine—Headache—Abacavir—acquired immunodeficiency syndrome	0.000101	0.000434	CcSEcCtD
Morphine—Infection—Lamivudine—acquired immunodeficiency syndrome	0.000101	0.000434	CcSEcCtD
Morphine—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	0.0001	0.000433	CcSEcCtD
Morphine—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.0001	0.000433	CcSEcCtD
Morphine—Pruritus—Zidovudine—acquired immunodeficiency syndrome	0.0001	0.000433	CcSEcCtD
Morphine—OPRD1—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	0.0001	0.00186	CbGpPWpGaD
Morphine—Insomnia—Ritonavir—acquired immunodeficiency syndrome	9.97e-05	0.00043	CcSEcCtD
Morphine—Shock—Lamivudine—acquired immunodeficiency syndrome	9.96e-05	0.00043	CcSEcCtD
Morphine—Nervous system disorder—Lamivudine—acquired immunodeficiency syndrome	9.92e-05	0.000428	CcSEcCtD
Morphine—Hypotension—Saquinavir—acquired immunodeficiency syndrome	9.91e-05	0.000428	CcSEcCtD
Morphine—Thrombocytopenia—Lamivudine—acquired immunodeficiency syndrome	9.91e-05	0.000428	CcSEcCtD
Morphine—OPRD1—GPCRs, Class A Rhodopsin-like—CCR5—acquired immunodeficiency syndrome	9.9e-05	0.00184	CbGpPWpGaD
Morphine—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	9.9e-05	0.000427	CcSEcCtD
Morphine—Urticaria—Efavirenz—acquired immunodeficiency syndrome	9.9e-05	0.000427	CcSEcCtD
Morphine—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	9.85e-05	0.000425	CcSEcCtD
Morphine—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	9.85e-05	0.000425	CcSEcCtD
Morphine—Skin disorder—Lamivudine—acquired immunodeficiency syndrome	9.83e-05	0.000424	CcSEcCtD
Morphine—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	9.83e-05	0.000424	CcSEcCtD
Morphine—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	9.82e-05	0.000424	CcSEcCtD
Morphine—ABCB1—Allograft Rejection—CD40LG—acquired immunodeficiency syndrome	9.81e-05	0.00182	CbGpPWpGaD
Morphine—ABCB1—Allograft Rejection—IL10—acquired immunodeficiency syndrome	9.81e-05	0.00182	CbGpPWpGaD
Morphine—Somnolence—Ritonavir—acquired immunodeficiency syndrome	9.8e-05	0.000423	CcSEcCtD
Morphine—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	9.78e-05	0.000422	CcSEcCtD
Morphine—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCR2—acquired immunodeficiency syndrome	9.76e-05	0.00181	CbGpPWpGaD
Morphine—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	9.75e-05	0.000421	CcSEcCtD
Morphine—OPRK1—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	9.72e-05	0.00181	CbGpPWpGaD
Morphine—Nausea—Nelfinavir—acquired immunodeficiency syndrome	9.72e-05	0.000419	CcSEcCtD
Morphine—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	9.71e-05	0.000419	CcSEcCtD
Morphine—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	9.7e-05	0.000419	CcSEcCtD
Morphine—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	9.7e-05	0.000419	CcSEcCtD
Morphine—Nausea—Stavudine—acquired immunodeficiency syndrome	9.69e-05	0.000418	CcSEcCtD
Morphine—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	9.66e-05	0.000417	CcSEcCtD
Morphine—Anorexia—Lamivudine—acquired immunodeficiency syndrome	9.65e-05	0.000416	CcSEcCtD
Morphine—OPRL1—Circadian rythm related genes—IL6—acquired immunodeficiency syndrome	9.62e-05	0.00179	CbGpPWpGaD
Morphine—Insomnia—Saquinavir—acquired immunodeficiency syndrome	9.59e-05	0.000414	CcSEcCtD
Morphine—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	9.58e-05	0.000413	CcSEcCtD
Morphine—Nausea—Abacavir—acquired immunodeficiency syndrome	9.54e-05	0.000412	CcSEcCtD
Morphine—ABCB1—Allograft Rejection—IL4—acquired immunodeficiency syndrome	9.54e-05	0.00177	CbGpPWpGaD
Morphine—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	9.53e-05	0.000411	CcSEcCtD
Morphine—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	9.52e-05	0.000411	CcSEcCtD
Morphine—Fatigue—Ritonavir—acquired immunodeficiency syndrome	9.5e-05	0.00041	CcSEcCtD
Morphine—OPRL1—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	9.49e-05	0.00176	CbGpPWpGaD
Morphine—Urticaria—Delavirdine—acquired immunodeficiency syndrome	9.47e-05	0.000409	CcSEcCtD
Morphine—Asthenia—Indinavir—acquired immunodeficiency syndrome	9.46e-05	0.000408	CcSEcCtD
Morphine—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	9.46e-05	0.000408	CcSEcCtD
Morphine—Hypotension—Lamivudine—acquired immunodeficiency syndrome	9.46e-05	0.000408	CcSEcCtD
Morphine—Somnolence—Saquinavir—acquired immunodeficiency syndrome	9.43e-05	0.000407	CcSEcCtD
Morphine—Pain—Ritonavir—acquired immunodeficiency syndrome	9.42e-05	0.000407	CcSEcCtD
Morphine—Constipation—Ritonavir—acquired immunodeficiency syndrome	9.42e-05	0.000407	CcSEcCtD
Morphine—OPRD1—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	9.42e-05	0.00175	CbGpPWpGaD
Morphine—OPRD1—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	9.42e-05	0.00175	CbGpPWpGaD
Morphine—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	9.42e-05	0.000407	CcSEcCtD
Morphine—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	9.42e-05	0.000407	CcSEcCtD
Morphine—OPRD1—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	9.42e-05	0.00175	CbGpPWpGaD
Morphine—Dizziness—Zidovudine—acquired immunodeficiency syndrome	9.37e-05	0.000405	CcSEcCtD
Morphine—OPRM1—Peptide ligand-binding receptors—CCR5—acquired immunodeficiency syndrome	9.37e-05	0.00174	CbGpPWpGaD
Morphine—OPRK1—G alpha (i) signalling events—CCR5—acquired immunodeficiency syndrome	9.35e-05	0.00174	CbGpPWpGaD
Morphine—OPRL1—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	9.35e-05	0.00174	CbGpPWpGaD
Morphine—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	9.34e-05	0.000403	CcSEcCtD
Morphine—ABCB1—Allograft Rejection—HLA-B—acquired immunodeficiency syndrome	9.33e-05	0.00173	CbGpPWpGaD
Morphine—Pruritus—Indinavir—acquired immunodeficiency syndrome	9.33e-05	0.000402	CcSEcCtD
Morphine—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	9.22e-05	0.000398	CcSEcCtD
Morphine—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	9.22e-05	0.000398	CcSEcCtD
Morphine—OPRD1—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	9.21e-05	0.00171	CbGpPWpGaD
Morphine—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	9.18e-05	0.000396	CcSEcCtD
Morphine—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCR4—acquired immunodeficiency syndrome	9.17e-05	0.0017	CbGpPWpGaD
Morphine—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCL12—acquired immunodeficiency syndrome	9.17e-05	0.0017	CbGpPWpGaD
Morphine—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	9.16e-05	0.000395	CcSEcCtD
Morphine—Insomnia—Lamivudine—acquired immunodeficiency syndrome	9.15e-05	0.000395	CcSEcCtD
Morphine—Fatigue—Saquinavir—acquired immunodeficiency syndrome	9.15e-05	0.000395	CcSEcCtD
Morphine—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	9.09e-05	0.000392	CcSEcCtD
Morphine—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	9.08e-05	0.000392	CcSEcCtD
Morphine—Pain—Saquinavir—acquired immunodeficiency syndrome	9.07e-05	0.000391	CcSEcCtD
Morphine—Constipation—Saquinavir—acquired immunodeficiency syndrome	9.07e-05	0.000391	CcSEcCtD
Morphine—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	9.02e-05	0.000389	CcSEcCtD
Morphine—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	9.02e-05	0.000389	CcSEcCtD
Morphine—Vomiting—Zidovudine—acquired immunodeficiency syndrome	9.01e-05	0.000389	CcSEcCtD
Morphine—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	9.01e-05	0.000389	CcSEcCtD
Morphine—Somnolence—Lamivudine—acquired immunodeficiency syndrome	9e-05	0.000388	CcSEcCtD
Morphine—OPRD1—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	8.98e-05	0.00167	CbGpPWpGaD
Morphine—Rash—Zidovudine—acquired immunodeficiency syndrome	8.94e-05	0.000386	CcSEcCtD
Morphine—Asthenia—Efavirenz—acquired immunodeficiency syndrome	8.94e-05	0.000386	CcSEcCtD
Morphine—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	8.93e-05	0.000385	CcSEcCtD
Morphine—UGT1A3—Metabolism—AGPS—acquired immunodeficiency syndrome	8.92e-05	0.00166	CbGpPWpGaD
Morphine—UGT2B7—Metabolism—TAT—acquired immunodeficiency syndrome	8.92e-05	0.00166	CbGpPWpGaD
Morphine—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	8.91e-05	0.000384	CcSEcCtD
Morphine—Headache—Zidovudine—acquired immunodeficiency syndrome	8.88e-05	0.000383	CcSEcCtD
Morphine—Pruritus—Efavirenz—acquired immunodeficiency syndrome	8.81e-05	0.00038	CcSEcCtD
Morphine—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	8.8e-05	0.00038	CcSEcCtD
Morphine—OPRK1—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	8.79e-05	0.00163	CbGpPWpGaD
Morphine—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	8.78e-05	0.000379	CcSEcCtD
Morphine—OPRM1—G alpha (i) signalling events—CCL5—acquired immunodeficiency syndrome	8.78e-05	0.00163	CbGpPWpGaD
Morphine—Urticaria—Ritonavir—acquired immunodeficiency syndrome	8.76e-05	0.000378	CcSEcCtD
Morphine—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	8.74e-05	0.000377	CcSEcCtD
Morphine—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	8.74e-05	0.000377	CcSEcCtD
Morphine—Fatigue—Lamivudine—acquired immunodeficiency syndrome	8.72e-05	0.000376	CcSEcCtD
Morphine—Dizziness—Indinavir—acquired immunodeficiency syndrome	8.72e-05	0.000376	CcSEcCtD
Morphine—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	8.71e-05	0.000376	CcSEcCtD
Morphine—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	8.71e-05	0.000376	CcSEcCtD
Morphine—OPRK1—GPCRs, Class A Rhodopsin-like—CCR5—acquired immunodeficiency syndrome	8.68e-05	0.00161	CbGpPWpGaD
Morphine—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	8.67e-05	0.000374	CcSEcCtD
Morphine—Constipation—Lamivudine—acquired immunodeficiency syndrome	8.65e-05	0.000373	CcSEcCtD
Morphine—Pain—Lamivudine—acquired immunodeficiency syndrome	8.65e-05	0.000373	CcSEcCtD
Morphine—OPRL1—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	8.62e-05	0.0016	CbGpPWpGaD
Morphine—OPRL1—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	8.55e-05	0.00159	CbGpPWpGaD
Morphine—Asthenia—Delavirdine—acquired immunodeficiency syndrome	8.55e-05	0.000369	CcSEcCtD
Morphine—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	8.52e-05	0.000368	CcSEcCtD
Morphine—OPRL1—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	8.49e-05	0.00158	CbGpPWpGaD
Morphine—OPRD1—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	8.48e-05	0.00158	CbGpPWpGaD
Morphine—Pruritus—Delavirdine—acquired immunodeficiency syndrome	8.43e-05	0.000364	CcSEcCtD
Morphine—Urticaria—Saquinavir—acquired immunodeficiency syndrome	8.43e-05	0.000364	CcSEcCtD
Morphine—Nausea—Zidovudine—acquired immunodeficiency syndrome	8.42e-05	0.000363	CcSEcCtD
Morphine—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	8.39e-05	0.000362	CcSEcCtD
Morphine—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	8.39e-05	0.000362	CcSEcCtD
Morphine—Vomiting—Indinavir—acquired immunodeficiency syndrome	8.38e-05	0.000362	CcSEcCtD
Morphine—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	8.34e-05	0.00036	CcSEcCtD
Morphine—OPRD1—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	8.33e-05	0.00155	CbGpPWpGaD
Morphine—Rash—Indinavir—acquired immunodeficiency syndrome	8.31e-05	0.000359	CcSEcCtD
Morphine—Dermatitis—Indinavir—acquired immunodeficiency syndrome	8.3e-05	0.000358	CcSEcCtD
Morphine—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	8.28e-05	0.000357	CcSEcCtD
Morphine—OPRK1—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	8.26e-05	0.00154	CbGpPWpGaD
Morphine—OPRK1—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	8.26e-05	0.00154	CbGpPWpGaD
Morphine—Headache—Indinavir—acquired immunodeficiency syndrome	8.26e-05	0.000356	CcSEcCtD
Morphine—OPRK1—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	8.26e-05	0.00153	CbGpPWpGaD
Morphine—Dizziness—Efavirenz—acquired immunodeficiency syndrome	8.24e-05	0.000355	CcSEcCtD
Morphine—OPRM1—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	8.21e-05	0.00153	CbGpPWpGaD
Morphine—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	8.15e-05	0.000352	CcSEcCtD
Morphine—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	8.12e-05	0.00035	CcSEcCtD
Morphine—OPRK1—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	8.07e-05	0.0015	CbGpPWpGaD
Morphine—Urticaria—Lamivudine—acquired immunodeficiency syndrome	8.04e-05	0.000347	CcSEcCtD
Morphine—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	8e-05	0.000345	CcSEcCtD
Morphine—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	8e-05	0.000345	CcSEcCtD
Morphine—Vomiting—Efavirenz—acquired immunodeficiency syndrome	7.92e-05	0.000342	CcSEcCtD
Morphine—Asthenia—Ritonavir—acquired immunodeficiency syndrome	7.91e-05	0.000341	CcSEcCtD
Morphine—OPRM1—G alpha (i) signalling events—CCR5—acquired immunodeficiency syndrome	7.91e-05	0.00147	CbGpPWpGaD
Morphine—Dizziness—Delavirdine—acquired immunodeficiency syndrome	7.88e-05	0.00034	CcSEcCtD
Morphine—OPRL1—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	7.87e-05	0.00146	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	7.87e-05	0.00146	CbGpPWpGaD
Morphine—Rash—Efavirenz—acquired immunodeficiency syndrome	7.85e-05	0.000339	CcSEcCtD
Morphine—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	7.85e-05	0.000339	CcSEcCtD
Morphine—Nausea—Indinavir—acquired immunodeficiency syndrome	7.83e-05	0.000338	CcSEcCtD
Morphine—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	7.82e-05	0.000337	CcSEcCtD
Morphine—Headache—Efavirenz—acquired immunodeficiency syndrome	7.8e-05	0.000337	CcSEcCtD
Morphine—Pruritus—Ritonavir—acquired immunodeficiency syndrome	7.8e-05	0.000336	CcSEcCtD
Morphine—OPRL1—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	7.77e-05	0.00144	CbGpPWpGaD
Morphine—Asthenia—Saquinavir—acquired immunodeficiency syndrome	7.61e-05	0.000328	CcSEcCtD
Morphine—UGT2B7—Metabolism—AGPS—acquired immunodeficiency syndrome	7.59e-05	0.00141	CbGpPWpGaD
Morphine—Vomiting—Delavirdine—acquired immunodeficiency syndrome	7.58e-05	0.000327	CcSEcCtD
Morphine—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	7.54e-05	0.000325	CcSEcCtD
Morphine—Rash—Delavirdine—acquired immunodeficiency syndrome	7.51e-05	0.000324	CcSEcCtD
Morphine—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	7.51e-05	0.000324	CcSEcCtD
Morphine—Pruritus—Saquinavir—acquired immunodeficiency syndrome	7.51e-05	0.000324	CcSEcCtD
Morphine—Headache—Delavirdine—acquired immunodeficiency syndrome	7.47e-05	0.000322	CcSEcCtD
Morphine—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	7.46e-05	0.000322	CcSEcCtD
Morphine—OPRK1—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	7.44e-05	0.00138	CbGpPWpGaD
Morphine—OPRM1—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	7.43e-05	0.00138	CbGpPWpGaD
Morphine—Nausea—Efavirenz—acquired immunodeficiency syndrome	7.4e-05	0.000319	CcSEcCtD
Morphine—OPRM1—GPCRs, Class A Rhodopsin-like—CCR5—acquired immunodeficiency syndrome	7.34e-05	0.00136	CbGpPWpGaD
Morphine—OPRK1—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	7.3e-05	0.00136	CbGpPWpGaD
Morphine—CYP2C8—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	7.29e-05	0.00135	CbGpPWpGaD
Morphine—Dizziness—Ritonavir—acquired immunodeficiency syndrome	7.29e-05	0.000314	CcSEcCtD
Morphine—Asthenia—Lamivudine—acquired immunodeficiency syndrome	7.26e-05	0.000313	CcSEcCtD
Morphine—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	7.26e-05	0.000313	CcSEcCtD
Morphine—UGT1A1—Metabolism—TAT—acquired immunodeficiency syndrome	7.25e-05	0.00135	CbGpPWpGaD
Morphine—OPRD1—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	7.17e-05	0.00133	CbGpPWpGaD
Morphine—Pruritus—Lamivudine—acquired immunodeficiency syndrome	7.16e-05	0.000309	CcSEcCtD
Morphine—OPRL1—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	7.12e-05	0.00132	CbGpPWpGaD
Morphine—Nausea—Delavirdine—acquired immunodeficiency syndrome	7.08e-05	0.000305	CcSEcCtD
Morphine—Dizziness—Saquinavir—acquired immunodeficiency syndrome	7.01e-05	0.000303	CcSEcCtD
Morphine—Vomiting—Ritonavir—acquired immunodeficiency syndrome	7.01e-05	0.000302	CcSEcCtD
Morphine—OPRM1—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	6.98e-05	0.0013	CbGpPWpGaD
Morphine—OPRM1—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	6.98e-05	0.0013	CbGpPWpGaD
Morphine—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	6.98e-05	0.0013	CbGpPWpGaD
Morphine—Rash—Ritonavir—acquired immunodeficiency syndrome	6.95e-05	0.0003	CcSEcCtD
Morphine—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	6.94e-05	0.0003	CcSEcCtD
Morphine—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	6.92e-05	0.000299	CcSEcCtD
Morphine—Headache—Ritonavir—acquired immunodeficiency syndrome	6.9e-05	0.000298	CcSEcCtD
Morphine—OPRM1—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	6.82e-05	0.00127	CbGpPWpGaD
Morphine—Vomiting—Saquinavir—acquired immunodeficiency syndrome	6.74e-05	0.000291	CcSEcCtD
Morphine—OPRL1—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	6.69e-05	0.00124	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	6.69e-05	0.00124	CbGpPWpGaD
Morphine—Dizziness—Lamivudine—acquired immunodeficiency syndrome	6.69e-05	0.000289	CcSEcCtD
Morphine—Rash—Saquinavir—acquired immunodeficiency syndrome	6.69e-05	0.000289	CcSEcCtD
Morphine—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	6.68e-05	0.000288	CcSEcCtD
Morphine—OPRM1—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	6.65e-05	0.00124	CbGpPWpGaD
Morphine—Headache—Saquinavir—acquired immunodeficiency syndrome	6.65e-05	0.000287	CcSEcCtD
Morphine—Nausea—Ritonavir—acquired immunodeficiency syndrome	6.55e-05	0.000282	CcSEcCtD
Morphine—OPRD1—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	6.46e-05	0.0012	CbGpPWpGaD
Morphine—Vomiting—Lamivudine—acquired immunodeficiency syndrome	6.43e-05	0.000278	CcSEcCtD
Morphine—Rash—Lamivudine—acquired immunodeficiency syndrome	6.38e-05	0.000275	CcSEcCtD
Morphine—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	6.37e-05	0.000275	CcSEcCtD
Morphine—Headache—Lamivudine—acquired immunodeficiency syndrome	6.34e-05	0.000274	CcSEcCtD
Morphine—Nausea—Saquinavir—acquired immunodeficiency syndrome	6.3e-05	0.000272	CcSEcCtD
Morphine—OPRK1—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	6.29e-05	0.00117	CbGpPWpGaD
Morphine—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	6.29e-05	0.00117	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	6.17e-05	0.00115	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—AGPS—acquired immunodeficiency syndrome	6.17e-05	0.00115	CbGpPWpGaD
Morphine—Nausea—Lamivudine—acquired immunodeficiency syndrome	6.01e-05	0.000259	CcSEcCtD
Morphine—OPRM1—TCR Signaling Pathway—IL6—acquired immunodeficiency syndrome	5.79e-05	0.00108	CbGpPWpGaD
Morphine—ABCB1—Allograft Rejection—IFNG—acquired immunodeficiency syndrome	5.77e-05	0.00107	CbGpPWpGaD
Morphine—OPRD1—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	5.69e-05	0.00106	CbGpPWpGaD
Morphine—OPRD1—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	5.66e-05	0.00105	CbGpPWpGaD
Morphine—OPRK1—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	5.66e-05	0.00105	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	5.44e-05	0.00101	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	5.44e-05	0.00101	CbGpPWpGaD
Morphine—OPRD1—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	5.33e-05	0.00099	CbGpPWpGaD
Morphine—OPRD1—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	5.33e-05	0.00099	CbGpPWpGaD
Morphine—OPRM1—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	5.31e-05	0.000987	CbGpPWpGaD
Morphine—OPRD1—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	5.14e-05	0.000956	CbGpPWpGaD
Morphine—ABCB1—Allograft Rejection—IL2—acquired immunodeficiency syndrome	5.13e-05	0.000953	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	5.09e-05	0.000946	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	5.02e-05	0.000932	CbGpPWpGaD
Morphine—OPRK1—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	4.99e-05	0.000927	CbGpPWpGaD
Morphine—OPRK1—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	4.97e-05	0.000923	CbGpPWpGaD
Morphine—OPRL1—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	4.94e-05	0.000918	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	4.92e-05	0.000914	CbGpPWpGaD
Morphine—OPRD1—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	4.84e-05	0.000899	CbGpPWpGaD
Morphine—OPRD1—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	4.84e-05	0.000899	CbGpPWpGaD
Morphine—OPRM1—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	4.79e-05	0.00089	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	4.77e-05	0.000886	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	4.77e-05	0.000886	CbGpPWpGaD
Morphine—OPRK1—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	4.67e-05	0.000868	CbGpPWpGaD
Morphine—OPRK1—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	4.67e-05	0.000868	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	4.59e-05	0.000852	CbGpPWpGaD
Morphine—OPRK1—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	4.51e-05	0.000838	CbGpPWpGaD
Morphine—OPRL1—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	4.49e-05	0.000834	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	4.31e-05	0.000801	CbGpPWpGaD
Morphine—OPRK1—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	4.24e-05	0.000788	CbGpPWpGaD
Morphine—OPRK1—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	4.24e-05	0.000788	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	4.22e-05	0.000783	CbGpPWpGaD
Morphine—OPRM1—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	4.2e-05	0.00078	CbGpPWpGaD
Morphine—OPRD1—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	4.05e-05	0.000753	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	4.03e-05	0.000749	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	4.03e-05	0.000749	CbGpPWpGaD
Morphine—OPRD1—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	3.99e-05	0.000742	CbGpPWpGaD
Morphine—OPRM1—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	3.95e-05	0.000733	CbGpPWpGaD
Morphine—OPRM1—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	3.95e-05	0.000733	CbGpPWpGaD
Morphine—UGT1A8—Metabolism—ALB—acquired immunodeficiency syndrome	3.91e-05	0.000726	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—TAT—acquired immunodeficiency syndrome	3.82e-05	0.00071	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	3.81e-05	0.000708	CbGpPWpGaD
Morphine—ABCB1—Allograft Rejection—TNF—acquired immunodeficiency syndrome	3.73e-05	0.000694	CbGpPWpGaD
Morphine—OPRD1—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	3.68e-05	0.000684	CbGpPWpGaD
Morphine—OPRD1—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	3.65e-05	0.000678	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	3.65e-05	0.000677	CbGpPWpGaD
Morphine—OPRD1—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	3.62e-05	0.000673	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	3.58e-05	0.000666	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	3.58e-05	0.000666	CbGpPWpGaD
Morphine—OPRK1—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	3.55e-05	0.00066	CbGpPWpGaD
Morphine—OPRK1—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	3.5e-05	0.00065	CbGpPWpGaD
Morphine—UGT2B15—Metabolism—ALB—acquired immunodeficiency syndrome	3.42e-05	0.000635	CbGpPWpGaD
Morphine—UGT2B4—Metabolism—ALB—acquired immunodeficiency syndrome	3.42e-05	0.000635	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	3.36e-05	0.000624	CbGpPWpGaD
Morphine—ABCB1—Metabolism—TAT—acquired immunodeficiency syndrome	3.33e-05	0.000618	CbGpPWpGaD
Morphine—OPRD1—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	3.31e-05	0.000616	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—AGPS—acquired immunodeficiency syndrome	3.25e-05	0.000603	CbGpPWpGaD
Morphine—OPRK1—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	3.23e-05	0.0006	CbGpPWpGaD
Morphine—OPRK1—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	3.2e-05	0.000595	CbGpPWpGaD
Morphine—OPRK1—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	3.18e-05	0.000591	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—TAT—acquired immunodeficiency syndrome	3.13e-05	0.000583	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	3.04e-05	0.000565	CbGpPWpGaD
Morphine—OPRM1—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	3e-05	0.000558	CbGpPWpGaD
Morphine—OPRM1—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	2.96e-05	0.00055	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	2.95e-05	0.000548	CbGpPWpGaD
Morphine—OPRK1—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	2.91e-05	0.00054	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	2.86e-05	0.000531	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	2.86e-05	0.000531	CbGpPWpGaD
Morphine—ABCB1—Metabolism—AGPS—acquired immunodeficiency syndrome	2.83e-05	0.000526	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	2.73e-05	0.000507	CbGpPWpGaD
Morphine—OPRM1—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	2.71e-05	0.000503	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	2.69e-05	0.000499	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—AGPS—acquired immunodeficiency syndrome	2.67e-05	0.000495	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	2.66e-05	0.000495	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—IL2—acquired immunodeficiency syndrome	2.65e-05	0.000493	CbGpPWpGaD
Morphine—OPRL1—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	2.64e-05	0.00049	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	2.51e-05	0.000466	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	2.51e-05	0.000466	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	2.49e-05	0.000463	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	2.46e-05	0.000456	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	2.25e-05	0.000418	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	2.17e-05	0.000404	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	2.14e-05	0.000398	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	2.12e-05	0.000393	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	2.12e-05	0.000393	CbGpPWpGaD
Morphine—OPRD1—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	2.11e-05	0.000392	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—TAT—acquired immunodeficiency syndrome	2.05e-05	0.000381	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.96e-05	0.000364	CbGpPWpGaD
Morphine—OPRD1—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.92e-05	0.000356	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.91e-05	0.000354	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.88e-05	0.000349	CbGpPWpGaD
Morphine—OPRK1—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.85e-05	0.000344	CbGpPWpGaD
Morphine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—acquired immunodeficiency syndrome	1.84e-05	0.000342	CbGpPWpGaD
Morphine—UGT1A3—Metabolism—ALB—acquired immunodeficiency syndrome	1.83e-05	0.00034	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—AGPS—acquired immunodeficiency syndrome	1.74e-05	0.000324	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.72e-05	0.000319	CbGpPWpGaD
Morphine—OPRK1—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.68e-05	0.000312	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.61e-05	0.000299	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.59e-05	0.000295	CbGpPWpGaD
Morphine—OPRM1—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.56e-05	0.00029	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—IL6—acquired immunodeficiency syndrome	1.56e-05	0.00029	CbGpPWpGaD
Morphine—UGT2B7—Metabolism—ALB—acquired immunodeficiency syndrome	1.56e-05	0.000289	CbGpPWpGaD
Morphine—CYP2C8—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	1.5e-05	0.000278	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.45e-05	0.00027	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.42e-05	0.000264	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—ALB—acquired immunodeficiency syndrome	1.26e-05	0.000235	CbGpPWpGaD
Morphine—ABCB1—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	1.24e-05	0.00023	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—IL2—acquired immunodeficiency syndrome	1.13e-05	0.00021	CbGpPWpGaD
Morphine—OPRD1—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	1.13e-05	0.000209	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—IL2—acquired immunodeficiency syndrome	9.92e-06	0.000184	CbGpPWpGaD
Morphine—OPRK1—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	9.87e-06	0.000183	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—IL2—acquired immunodeficiency syndrome	8.38e-06	0.000156	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	8.34e-06	0.000155	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—ALB—acquired immunodeficiency syndrome	6.66e-06	0.000124	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—IL6—acquired immunodeficiency syndrome	6.65e-06	0.000124	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—IL6—acquired immunodeficiency syndrome	5.83e-06	0.000108	CbGpPWpGaD
Morphine—ABCB1—Metabolism—ALB—acquired immunodeficiency syndrome	5.8e-06	0.000108	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—ALB—acquired immunodeficiency syndrome	5.47e-06	0.000102	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—IL6—acquired immunodeficiency syndrome	4.93e-06	9.16e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—ALB—acquired immunodeficiency syndrome	3.57e-06	6.64e-05	CbGpPWpGaD
